Prior studies have suggested that nucleic acid solution polymers (NAPs) may reduce circulating degrees of HBsAg in the blood by blocking its release from contaminated hepatocytes and that effect may have medical benefit. raises in serum anti-HBsAg antibody titers before drawback of therapy. For 52 weeks after removal of REP 2055 therapy, rebound of serum… Continue reading Prior studies have suggested that nucleic acid solution polymers (NAPs) may